癌症患者-话题@MedSci

#癌症患者#

374篇内容 | 6636人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1289640, encodeId=f5db128964018, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=支持/姑息治疗：患者导航干预研究：显著增加转移性癌症患者早期获得支持性护理机会, objectType=article, longId=168970, objectId=f5301689e0db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5301689e0db, replyNumber=0, likeNumber=57, createdTime=2019-06-24, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5301689e0db, moduleTitle=支持/姑息治疗：患者导航干预研究：显著增加转移性癌症患者早期获得支持性护理机会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5301689e0db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289639, encodeId=95451289639b3, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=JAHA：胸部、头颈部放射治疗后癌症患者他汀类药物使用与血管事件风险, objectType=article, longId=168915, objectId=0bed168915da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bed168915da, replyNumber=0, likeNumber=98, createdTime=2019-06-23, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bed168915da, moduleTitle=JAHA：胸部、头颈部放射治疗后癌症患者他汀类药物使用与血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bed168915da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289638, encodeId=9fa7128963844, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理, objectType=article, longId=168196, objectId=b6b3168196f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b3168196f9, replyNumber=0, likeNumber=44, createdTime=2019-06-13, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b3168196f9, moduleTitle=2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b3168196f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289637, encodeId=d630128963e69, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=从聊城假药门聊一聊被癌症患者高估的希望, objectType=article, longId=166708, objectId=c70a166e084b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c70a166e084b, replyNumber=0, likeNumber=62, createdTime=2019-05-25, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c70a166e084b, moduleTitle=从聊城假药门聊一聊被癌症患者高估的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c70a166e084b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289636, encodeId=9832128963659, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=J Thromb Haemost：全血细胞计数、d-二聚体和可溶性P-选择素与癌症患者动脉血栓栓塞风险的关联, objectType=article, longId=166315, objectId=b4f516631583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f516631583, replyNumber=0, likeNumber=0, createdTime=2019-05-20, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f516631583, moduleTitle=J Thromb Haemost：全血细胞计数、d-二聚体和可溶性P-选择素与癌症患者动脉血栓栓塞风险的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f516631583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289635, encodeId=c35212896355b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=J Thromb Haemost：血液系统癌症患者血栓栓塞和出血的风险, objectType=article, longId=165562, objectId=93a71655627e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93a71655627e, replyNumber=0, likeNumber=71, createdTime=2019-05-08, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93a71655627e, moduleTitle=J Thromb Haemost：血液系统癌症患者血栓栓塞和出血的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93a71655627e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289634, encodeId=7e7f1289634a1, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=绝大多数癌症患者都在忍受着疼痛疼痛管理刻不容缓, objectType=article, longId=165492, objectId=b9b91654921a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9b91654921a, replyNumber=0, likeNumber=67, createdTime=2019-05-08, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9b91654921a, moduleTitle=绝大多数癌症患者都在忍受着疼痛疼痛管理刻不容缓, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9b91654921a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289633, encodeId=e0f91289633bd, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=2019 AHA科学声明：癌症患者和生存者心脏-肿瘤康复管理心血管结局, objectType=article, longId=165283, objectId=363b165283b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=363b165283b8, replyNumber=0, likeNumber=44, createdTime=2019-05-02, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=363b165283b8, moduleTitle=2019 AHA科学声明：癌症患者和生存者心脏-肿瘤康复管理心血管结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=363b165283b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289632, encodeId=e44612896329b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=2019 JSPM临床指南：癌症患者胃肠道症状的管理建议, objectType=article, longId=164925, objectId=642816492548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642816492548, replyNumber=0, likeNumber=18, createdTime=2019-04-25, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642816492548, moduleTitle=2019 JSPM临床指南：癌症患者胃肠道症状的管理建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=642816492548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289631, encodeId=82b1128963180, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=FDA批准NKMax America的NK细胞疗法SNK01用于难治性癌症患者的1期临床试验, objectType=article, longId=161784, objectId=176a161e8475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=176a161e8475, replyNumber=0, likeNumber=51, createdTime=2019-03-08, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=176a161e8475, moduleTitle=FDA批准NKMax America的NK细胞疗法SNK01用于难治性癌症患者的1期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=176a161e8475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289630, encodeId=906912896308c, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=NEJM：利伐沙班用于高风险门诊癌症患者的血栓预防, objectType=article, longId=160697, objectId=17c516069ec8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17c516069ec8, replyNumber=0, likeNumber=62, createdTime=2019-02-22, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17c516069ec8, moduleTitle=NEJM：利伐沙班用于高风险门诊癌症患者的血栓预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17c516069ec8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289629, encodeId=34fe12896290a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=NEJM：阿哌沙班预防癌症患者的静脉血栓栓塞, objectType=article, longId=160695, objectId=0b84160695a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b84160695a0, replyNumber=0, likeNumber=90, createdTime=2019-02-22, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b84160695a0, moduleTitle=NEJM：阿哌沙班预防癌症患者的静脉血栓栓塞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b84160695a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289628, encodeId=714c12896281e, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Plos one：癌症患者是否会抑郁，让AI工具来告诉你, objectType=article, longId=159277, objectId=c4781592e798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4781592e798, replyNumber=0, likeNumber=62, createdTime=2019-02-01, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4781592e798, moduleTitle=Plos one：癌症患者是否会抑郁，让AI工具来告诉你, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4781592e798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289627, encodeId=c89c128962e12, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=N Engl J Med：癌症患者口服阿哌沙班预防静脉血栓栓塞效果如何？, objectType=article, longId=158948, objectId=921915894893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=921915894893, replyNumber=0, likeNumber=54, createdTime=2019-01-28, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=921915894893, moduleTitle=N Engl J Med：癌症患者口服阿哌沙班预防静脉血栓栓塞效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=921915894893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289626, encodeId=67c31289626a0, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=【急重症科】ICU的癌症患者, objectType=article, longId=157795, objectId=854e15e79511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=854e15e79511, replyNumber=0, likeNumber=67, createdTime=2019-01-12, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=854e15e79511, moduleTitle=【急重症科】ICU的癌症患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=854e15e79511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289625, encodeId=e2c512896257f, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Ann Oncol：癌症患者，纳武单抗每4周480 mg给药方案靠谱吗？, objectType=article, longId=157761, objectId=9e4615e76119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e4615e76119, replyNumber=0, likeNumber=60, createdTime=2019-01-12, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e4615e76119, moduleTitle=Ann Oncol：癌症患者，纳武单抗每4周480 mg给药方案靠谱吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e4615e76119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289624, encodeId=f109128962482, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Eur Heart J：癌症患者与经皮冠状动脉介入治疗, objectType=article, longId=154920, objectId=308915492033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=308915492033, replyNumber=0, likeNumber=78, createdTime=2018-12-03, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=308915492033, moduleTitle=Eur Heart J：癌症患者与经皮冠状动脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=308915492033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289623, encodeId=9e52128962334, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=新药与放疗联合应用于癌症患者可显著提高放疗效果, objectType=article, longId=154035, objectId=044b15403565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044b15403565, replyNumber=0, likeNumber=72, createdTime=2018-11-22, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044b15403565, moduleTitle=新药与放疗联合应用于癌症患者可显著提高放疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044b15403565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289622, encodeId=923b128962204, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Ann Oncol：老年癌症患者的依从性如何？哪种建议的依从性**？, objectType=article, longId=152050, objectId=36131520505a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36131520505a, replyNumber=0, likeNumber=72, createdTime=2018-10-29, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36131520505a, moduleTitle=Ann Oncol：老年癌症患者的依从性如何？哪种建议的依从性**？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36131520505a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289621, encodeId=f7f4128962123, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Ann Oncol：G-CSF+化疗可显著改善癌症患者的总生存期？, objectType=article, longId=152047, objectId=682715204e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=682715204e1c, replyNumber=0, likeNumber=90, createdTime=2018-10-29, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=682715204e1c, moduleTitle=Ann Oncol：G-CSF+化疗可显著改善癌症患者的总生存期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=682715204e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

癌症患者

2020-05-29

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

支持/姑息治疗：患者导航干预研究：显著增加转移性癌症患者早期获得支持性护理机会

2019-06-24

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

JAHA：胸部、头颈部放射治疗后癌症患者他汀类药物使用与血管事件风险

2019-06-23

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理

2019-06-13

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

从聊城假药门聊一聊被癌症患者高估的希望

2019-05-25

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

J Thromb Haemost：全血细胞计数、d-二聚体和可溶性P-选择素与癌症患者动脉血栓栓塞风险的关联

2019-05-20

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

J Thromb Haemost：血液系统癌症患者血栓栓塞和出血的风险

2019-05-08

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

绝大多数癌症患者都在忍受着疼痛疼痛管理刻不容缓

2019-05-08

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

2019 AHA科学声明：癌症患者和生存者心脏-肿瘤康复管理心血管结局

2019-05-02

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

2019 JSPM临床指南：癌症患者胃肠道症状的管理建议

2019-04-25

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

FDA批准NKMax America的NK细胞疗法SNK01用于难治性癌症患者的1期临床试验

2019-03-08

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

NEJM：利伐沙班用于高风险门诊癌症患者的血栓预防

2019-02-22

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

NEJM：阿哌沙班预防癌症患者的静脉血栓栓塞

2019-02-22

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Plos one：癌症患者是否会抑郁，让AI工具来告诉你

2019-02-01

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

N Engl J Med：癌症患者口服阿哌沙班预防静脉血栓栓塞效果如何？

2019-01-28

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

【急重症科】ICU的癌症患者

2019-01-12

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Ann Oncol：癌症患者，纳武单抗每4周480 mg给药方案靠谱吗？

2019-01-12

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Eur Heart J：癌症患者与经皮冠状动脉介入治疗

2018-12-03

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

新药与放疗联合应用于癌症患者可显著提高放疗效果

2018-11-22

爆笑小医 (审核中...)

前往app查看评论内容

#癌症患者#

Ann Oncol：老年癌症患者的依从性如何？哪种建议的依从性**？

2018-10-29

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Ann Oncol：G-CSF+化疗可显著改善癌症患者的总生存期？

2018-10-29

科室
- - 订阅+
  - 更多科室
工具
服务